4 days ago · “As Lantheus continues to advance its industry leadership, this transaction, along with the agreement to acquire Life Molecular Imaging, enhances our operations across the …

2 days ago · US-based radiopharmaceutical company Lantheus has announced a definitive agreement to acquire clinical-stage radiopharma contract development and manufacturing …

4 days ago · Lantheus Logo. This transaction is expected to solidify Lantheus' capabilities as a fully integrated radiopharmaceutical company. The addition of Evergreen's scalable …

4 days ago · "Today marks an exciting new chapter for Evergreen as we look to join the Lantheus team," said James Cook, CEO of Evergreen. "Lantheus' industry expertise and financial …

3 days ago · Lantheus has reached an agreement to acquire radiopharmaceutical firm Evergreen Theragnostics for up to $1 billion, the two announced Tuesday. Founded in 2019 and …

4 days ago · Evergreen’s ability to work with a variety of diagnostic and therapeutic isotopes will enhance Lantheus’ ability to address the complexities of radiopharmaceutical development …

3 days ago · New York – January 28, 2025 – Cooley advised Lantheus Holdings (Nasdaq: LNTH), a radiopharmaceutical-focused company committed to enabling clinicians to find, fight and …

3 days ago · “As Lantheus continues to advance its industry leadership, this transaction, along with the agreement to acquire Life Molecular Imaging, enhances our operations across the …

3 days ago · Lantheus stock fell 6.3% by midday Tuesday, giving the company a market capitalization of $6.4 billion. Don't miss out on Boston-area life science news. Subscribe to the …

4 days ago · Lantheus will acquire Evergreen Theragnostics for $250 million upfront, plus up to $752.5 million in milestone payments, closing in H2 2025. The Life Molecular Imaging …